Knocking down PMCA2 expression in breast cancer cell lines results in an increase in intracellular calcium concentrations around the active HER2 signaling complex, which, in turn promotes the ubiquitination, internalization and degradation of HER2. The gene discussed is ERBB2; the disease is breast cancer.